Skip to main content

Kenvue to Announce First Quarter 2024 Results on May 7, 2024

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Kenvue Inc. (NYSE: KVUE) (“Kenvue”), the world’s largest pure-play consumer health company by revenue, will announce its financial results for the first quarter ending March 31, 2024, before market open on May 7, 2024.

The company will host a conference call and webcast at 8:30 a.m. Eastern Time to discuss the financial results. The conference call can be accessed by dialing 888-672-2415 from the U.S. or +1 646-307-1952 from international locations. The conference ID for all callers is 14840. A live webcast of the conference call will be available at investors.kenvue.com. A replay will be available after the live event.

About Kenvue

Kenvue is the world’s largest pure-play consumer health company by revenue. Built on more than a century of heritage, our iconic brands, including Aveeno®, BAND-AID® Brand Adhesive Bandages, Johnson’s®, Listerine®, Neutrogena® and Tylenol®, are science-backed and recommended by healthcare professionals around the world. At Kenvue, we believe in the extraordinary power of everyday care and our teams work every day to put that power in consumers’ hands and earn a place in their hearts and homes. Learn more at www.kenvue.com.

Contacts

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  248.43
-0.07 (-0.03%)
AAPL  263.62
-2.81 (-1.05%)
AMD  274.48
+16.36 (6.34%)
BAC  53.72
-0.60 (-1.10%)
GOOG  332.11
-2.36 (-0.71%)
META  673.54
+1.96 (0.29%)
MSFT  418.48
+7.26 (1.77%)
NVDA  198.15
-0.72 (-0.36%)
ORCL  177.10
+7.29 (4.29%)
TSLA  387.25
-4.70 (-1.20%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.